MENVEO
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsBy this time of the year, the street usually has a fair idea of the allocations made to emerging markets by the US and other global investo...
Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capabili...
- Novartis says Q1 profit up 49 pcDrug maker Novartis AG said on Tuesday that strong sales particularly of swine flu vaccine helped increase net profit by 49 per cent to $2....
- Novartis gets US approval for meningitis vaccineNovartis AG said that its meningitis vaccine Menveo has been approved for use in teenagers and adults by the US Food and Drug Administratio...
- New meningitis vaccine for infants shows promiseA new vaccine, Menveo, has shown promise in clinical trials, which might help protect infants against four types of meningitis.
Load More- Novartis says Q1 profit up 49 pc